Patents by Inventor Annika MEHLEM

Annika MEHLEM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240002488
    Abstract: The present disclosure provides a method of treating a nonalcoholic fatty liver disease in a subject, the method comprising administering to the subject a compound that inhibits VEGF-B signaling.
    Type: Application
    Filed: November 9, 2022
    Publication date: January 4, 2024
    Inventors: Annika MEHLEM, Ulf ERIKSSON, Annelie FALKEVALL, Isolde PALOMBO
  • Patent number: 11261243
    Abstract: The present disclosure provides a method of treating diabetic nephropathy in a subject suffering from diabetic nephropathy, the method comprising administering to the subject a compound that inhibits VEGF-B signaling.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: March 1, 2022
    Assignees: CSL LIMITED, B-CREATIVE SWEDEN AB
    Inventors: Ulf Eriksson, Annelie Falkevall, Annika Mehlem
  • Publication number: 20210269517
    Abstract: The present disclosure provides a method of treating a wasting disorder in a subject, the method comprising administering to the subject a compound that inhibits VEGF-B signalling. The present disclosure also provides a method of treating cancer cachexia in a subject suffering from cancer cachexia, the method comprising 5 administering to the subject a compound that inhibits VEGF-B signaling.
    Type: Application
    Filed: September 18, 2019
    Publication date: September 2, 2021
    Applicants: CSL Limited, CSL Innovation Pty Ltd, B-Creative Sweden AB
    Inventors: Ulf ERIKSSON, Annelie FALKEVALL, Annika MEHLEM, Isolde PALOMBO, Samuel WRIGHT
  • Patent number: 10543270
    Abstract: The present disclosure provides a method of treating wound healing in a subject, the method comprising administering to the subject a compound that inhibits VEGF-B signalling.
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: January 28, 2020
    Assignees: CSL LIMITED, B-CREATIVE SWEDEN AB
    Inventors: Ulf Eriksson, Annelie Falkevall, Annika Mehlem
  • Publication number: 20200010541
    Abstract: The present disclosure provides a method of treating diabetic nephropathy in a subject suffering from diabetic nephropathy, the method comprising administering to the subject a compound that inhibits VEGF-B signaling.
    Type: Application
    Filed: July 24, 2019
    Publication date: January 9, 2020
    Applicants: CSL LIMITED, B-CREATIVE SWEDEN AB
    Inventors: Ulf Eriksson, Annelie Falkevall, Annika Mehlem
  • Patent number: 10407498
    Abstract: The present disclosure provides a method of treating diabetic nephropathy in a subject suffering from diabetic nephropathy, the method comprising administering to the subject a compound that inhibits VEGF-B signalling.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: September 10, 2019
    Assignees: CSL LIMITED, B-CREATIVE SWEDEN AB
    Inventors: Ulf Eriksson, Annelie Falkevall, Annika Mehlem
  • Publication number: 20190119369
    Abstract: The present disclosure provides a method of treating a nonalcoholic fatty liver disease in a subject, the method comprising administering to the subject a compound that inhibits VEGF-B signalling.
    Type: Application
    Filed: April 21, 2017
    Publication date: April 25, 2019
    Inventors: Annika MEHLEM, Ulf ERIKSSON, Annelie FALKEVALL, Isolde PALOMBO
  • Publication number: 20180086824
    Abstract: The present disclosure provides a method of treating diabetic nephropathy in a subject suffering from diabetic nephropathy, the method comprising administering to the subject a compound that inhibits VEGF-B signalling.
    Type: Application
    Filed: September 28, 2017
    Publication date: March 29, 2018
    Applicants: CSL LIMITED, B-CREATIVE SWEDEN AB
    Inventors: Ulf ERIKSSON, Annelie FALKEVALL, Annika MEHLEM
  • Patent number: 9803008
    Abstract: The present disclosure provides a method of treating diabetic nephropathy in a subject suffering from diabetic nephropathy, the method comprising administering to the subject a compound that inhibits VEGF-B signalling.
    Type: Grant
    Filed: November 28, 2014
    Date of Patent: October 31, 2017
    Assignees: CSL Limited, B-CREATIVE SWEDEN AB
    Inventors: Ulf Eriksson, Annelie Falkevall, Annika Mehlem
  • Publication number: 20170037119
    Abstract: The present disclosure provides a method of treating diabetic nephropathy in a subject suffering from diabetic nephropathy, the method comprising administering to the subject a compound that inhibits VEGF-B signalling.
    Type: Application
    Filed: November 28, 2014
    Publication date: February 9, 2017
    Applicants: CSL LIMITED, B-CREATIVE SWEDEN AB
    Inventors: Ulf ERIKSSON, Annelie FALKEVALL, Annika MEHLEM
  • Publication number: 20160319008
    Abstract: The present disclosure provides a method of treating wound healing in a subject, the method comprising administering to the subject a compound that inhibits VEGF-B signalling.
    Type: Application
    Filed: December 18, 2014
    Publication date: November 3, 2016
    Applicants: CSL LIMITED, B-CREATIVE SWEDEN AB
    Inventors: Ulf ERIKSSON, Annelie FALKEVALL, Annika MEHLEM